Dongying Gu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Long Noncoding Rna

Replacement Therapy

Papillary Thyroid

Angiotensin Converting Enzyme

Top Venues

Clinical and translational medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Shuwei Li, Mulong Du, Kaili Xu, Shuai Ben, Tianru Zhu, Mengfan Guo, Junyi Xin, Ling-Jun Zhu, Dongying Gu, Zhengdong Zhang, Meilin Wang
A germline variant in the BET1L 3'-UTR confers colorectal cancer susceptibility by reducing miRNA binding and m6A modification. Cancer research (2023)
Shuwei Li, Silu Chen, Qiuyuan Zhu, Shuai Ben, Fang Gao, Junyi Xin, Mulong Du, Haiyan Chu, Dongying Gu, Zhengdong Zhang, Meilin Wang
The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer. Clinical and translational medicine 12 (7) (2022)
Yixuan Meng, Shuwei Li, Qiuyi Zhang, Shuai Ben, Qiuyuan Zhu, Mulong Du, Dongying Gu
LncRNA-422 suppresses the proliferation and growth of colorectal cancer cells by targeting SFPQ. Clinical and translational medicine 12 (1) (2022)